AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Buys $136,800.00 in Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett purchased 80,000 shares of the firm’s stock in a transaction dated Tuesday, March 3rd. The stock was purchased at an average cost of $1.71 per share, with a total value of $136,800.00. Following the acquisition, the insider directly owned 6,322,611 shares in the company, valued at $10,811,664.81. This trade represents a 1.28% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Wednesday, March 4th, Jorey Chernett acquired 30,000 shares of AirSculpt Technologies stock. The shares were acquired at an average cost of $1.87 per share, for a total transaction of $56,100.00.

AirSculpt Technologies Trading Up 5.8%

NASDAQ:AIRS traded up $0.10 on Wednesday, reaching $1.84. The company’s stock had a trading volume of 448,173 shares, compared to its average volume of 608,136. AirSculpt Technologies, Inc. has a 1-year low of $1.51 and a 1-year high of $12.00. The business’s 50-day moving average price is $2.21 and its two-hundred day moving average price is $4.91. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.63.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Leerink Partners restated a “market perform” rating and set a $6.00 price objective on shares of AirSculpt Technologies in a report on Tuesday, November 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $6.00.

Hedge Funds Weigh In On AirSculpt Technologies

A number of institutional investors have recently added to or reduced their stakes in AIRS. Vesey Street Capital Partners L.L.C. lifted its position in shares of AirSculpt Technologies by 3.4% in the second quarter. Vesey Street Capital Partners L.L.C. now owns 30,324,180 shares of the company’s stock valued at $146,466,000 after buying an additional 1,000,000 shares during the last quarter. Balyasny Asset Management L.P. lifted its holdings in AirSculpt Technologies by 128.5% during the 2nd quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock valued at $5,380,000 after purchasing an additional 626,309 shares during the last quarter. Renaissance Technologies LLC bought a new position in AirSculpt Technologies during the fourth quarter worth $1,991,000. Vanguard Group Inc. boosted its position in AirSculpt Technologies by 10.8% during the third quarter. Vanguard Group Inc. now owns 782,543 shares of the company’s stock worth $6,276,000 after purchasing an additional 76,291 shares during the period. Finally, Geode Capital Management LLC increased its holdings in shares of AirSculpt Technologies by 4.6% in the fourth quarter. Geode Capital Management LLC now owns 403,163 shares of the company’s stock valued at $798,000 after purchasing an additional 17,889 shares during the last quarter. 91.54% of the stock is currently owned by institutional investors and hedge funds.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.